메뉴 건너뛰기




Volumn 25, Issue 2, 2014, Pages 652-662

Reducing barriers to Hepatitis C treatment among drug users: An integrated Hepatitis C Peer Education and support program

Author keywords

Hepatitis C; Injection drug users; Methadone; Opiate agonist treatment; Peer education

Indexed keywords

ADULT; COMPLICATION; CONFIDENTIALITY; FEMALE; HEALTH CARE DELIVERY; HEPATITIS C, CHRONIC; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PEER GROUP; PROCEDURES; PSYCHOLOGY; SOCIAL SUPPORT; SUBSTANCE ABUSE;

EID: 84901247832     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2014.0096     Document Type: Article
Times cited : (44)

References (16)
  • 1
    • 33646852746 scopus 로고    scopus 로고
    • The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
    • May 16
    • Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006 May 16;144(10):705-14. http:// dx.doi.org/ 10.7326/ 0003-4819-144-10-200605160-00004
    • (2006) Ann Intern Med , vol.144 , Issue.10 , pp. 705-714
    • Armstrong, G.L.1    Wasley, A.2    Simard, E.P.3
  • 2
    • 67349223905 scopus 로고    scopus 로고
    • Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program
    • Jul, Epub 2008 Nov 28
    • Litwin AH, Harris KA, Nahvi S, et al. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat. 2009 Jul;37(1):32-40. Epub 2008 Nov 28. http:// dx.doi.org/ 10.1016/ j.jsat.2008.09.009
    • (2009) J Subst Abuse Treat. , vol.37 , Issue.1 , pp. 32-40
    • Litwin, A.H.1    Harris, K.A.2    Nahvi, S.3
  • 3
    • 0037229595 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 June 10-12, 2002
    • National Institutes of Health, Jan-Feb
    • National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 June 10-12, 2002. HIV Clin Trials. 2003 Jan-Feb;4(1):55-75. http:// dx.doi.org/ 10.1310/ 86XW-Y6PX-TNE7-YM7J
    • (2003) HIV Clin Trials. , vol.4 , Issue.1 , pp. 55-75
  • 4
    • 77953024803 scopus 로고    scopus 로고
    • Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance
    • Jun 1, Epub 2010 Feb 18
    • Schulte B, Schutt S, Brack J, et al. Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug Alcohol Depend. 2010 Jun 1;109(1-3):248-51. Epub 2010 Feb 18. http:// dx.doi.org / 10.1016/ j.drugalcdep.2010.01.009
    • (2010) Drug Alcohol Depend. , vol.109 , Issue.1-3 , pp. 248-251
    • Schulte, B.1    Schutt, S.2    Brack, J.3
  • 5
    • 84867311786 scopus 로고    scopus 로고
    • Hepatitis C virus prevention, care, and treatment: From policy to practice
    • Jul
    • Ward JW, Valdiserri RO, Koh HK. Hepatitis C virus prevention, care, and treatment: from policy to practice. Clin Infect Dis. 2012 Jul;55 Suppl 1:S58-63. http:// dx.doi.org / 10.1093/ cid/ cis392
    • (2012) Clin Infect Dis , vol.55 , Issue.SUPPL. 1
    • Ward, J.W.1    Valdiserri, R.O.2    Koh, H.K.3
  • 6
    • 67651083226 scopus 로고    scopus 로고
    • Hepatitis C treatment for injection drug users: A review of the available evidence
    • Aug 15
    • Hellard M, Sacks Davis R, Gold J. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin Infect Dis. 2009 Aug 15;49(4):561-73. http:// dx.doi.org/ 10.1086/ 600304
    • (2009) Clin Infect Dis. , vol.49 , Issue.4 , pp. 561-573
    • Hellard, M.1    Sacks Davis, R.2    Gold, J.3
  • 7
    • 43349090325 scopus 로고    scopus 로고
    • Limited uptake of hepatitis C treatment among injection drug users
    • Jun
    • Mehta SH, Genberg BL, Astemborski J, et al. Limited uptake of hepatitis C treatment among injection drug users. J Community Health. 2008 Jun;33(3):126-33. http:// dx.doi.org/ 10.1007/ s10900-007-9083-3
    • (2008) J Community Health. , vol.33 , Issue.3 , pp. 126-133
    • Mehta, S.H.1    Genberg, B.L.2    Astemborski, J.3
  • 8
    • 0032734207 scopus 로고    scopus 로고
    • Needle-exchange attendance and health care utilization promote entry into detoxification
    • Dec
    • Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999 Dec;76(4):448-60. http:// dx.doi.org/ 10.1007/ BF02351502
    • (1999) J Urban Health. , vol.76 , Issue.4 , pp. 448-460
    • Strathdee, S.A.1    Celentano, D.D.2    Shah, N.3
  • 9
    • 75149163334 scopus 로고    scopus 로고
    • Aging of hepatitis C virus (HCV)-infected persons in the United States: A multiple cohort model of HCV prevalence and disease progression
    • Feb, Epub 2009 Oct 25
    • Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010 Feb;138(2):513-21. Epub 2009 Oct 25. http:// dx.doi.org/ 10.1053/ j.gastro.2009.09.067
    • (2010) Gastroenterology. , vol.138 , Issue.2 , pp. 513-521
    • Davis, G.L.1    Alter, M.J.2    El-Serag, H.3
  • 10
    • 0035913229 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis C in active drug users
    • Jul 19
    • Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med. 2001 Jul 19;345(3):215-7. http:// dx.doi.org/ 10.1056/ NEJM200107193450312
    • (2001) N Engl J Med. , vol.345 , Issue.3 , pp. 215-217
    • Davis, G.L.1    Rodrigue, J.R.2
  • 11
    • 0035913261 scopus 로고    scopus 로고
    • Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
    • Jul 19
    • Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med. 2001 Jul 19; 345(3), 211-5. http:// dx.doi.org / 10.1056/ NEJM200107193450311
    • (2001) N Engl J Med , vol.345 , Issue.3 , pp. 211-215
    • Edlin, B.R.1    Seal, K.H.2    Lorvick, J.3
  • 12
    • 16844384955 scopus 로고    scopus 로고
    • Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users
    • Apr 15
    • Edlin BR, Kresina TF, Raymond DB, et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S276-85. http:// dx.doi.org/ 10.1086/ 427441
    • (2005) Clin Infect Dis , vol.40 , Issue.SUPPL. 5
    • Edlin, B.R.1    Kresina, T.F.2    Raymond, D.B.3
  • 13
    • 43349090325 scopus 로고    scopus 로고
    • Limited Uptake of Hepatitis C Treatment Among Injection Drug Users
    • Jun
    • Mehta SH, Genberg BL, Astemborski J, et al. Limited Uptake of Hepatitis C Treatment Among Injection Drug Users. J Community Health. 2008 Jun;33(3):126-33. http:// dx.doi.org/ 10.1007/ s10900-007-9083-3
    • (2008) J Community Health. , vol.33 , Issue.3 , pp. 126-133
    • Mehta, S.H.1    Genberg, B.L.2    Astemborski, J.3
  • 14
    • 38849099640 scopus 로고    scopus 로고
    • Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U. S
    • Feb, Epub 2007 Aug 6
    • Munoz-Plaza CE, Strauss S, Astone-Twerell J, et al. Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. Int J Drug Policy. 2008 Feb;19(1):71-8. Epub 2007 Aug 6.
    • (2008) Int J Drug Policy. , vol.19 , Issue.1 , pp. 71-78
    • Munoz-Plaza, C.E.1    Strauss, S.2    Astone-Twerell, J.3
  • 15
    • 16844376913 scopus 로고    scopus 로고
    • Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: Challenges and opportunities
    • Apr 15
    • Litwin AH, Soloway I, Gourevitch MN. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis. 2005 Apr 15;40(Suppl 5):S339-45. http:// dx.doi.org/ 10.1086/ 427450
    • (2005) Clin Infect Dis. , vol.40 , Issue.SUPPL. 5
    • Litwin, A.H.1    Soloway, I.2    Gourevitch, M.N.3
  • 16
    • 84868147307 scopus 로고    scopus 로고
    • Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program
    • Dec, Epub 2012 Oct 2
    • Stein MR, Soloway IJ, Jefferson KS, et al. Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. J Subst Abuse Treat. 2012 Dec;43(4):424-32. Epub 2012 Oct 2. http:// dx.doi.org / 10.1016/ j.jsat.2012.08.007
    • (2012) J Subst Abuse Treat. , vol.43 , Issue.4 , pp. 424-432
    • Stein, M.R.1    Soloway, I.J.2    Jefferson, K.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.